Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 8Unknown 4Recruiting 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Breast 3Thoracic 2Genitourinary 1

Conditions

Pancreatic Neoplasms 2Pain, Postoperative 1Liver Neoplasms 1Duodenal Neoplasms 1Agnosia 1

Interventions

Oxaliplatin 197Bevacizumab 162Fluorouracil 155Capecitabine 137Gemcitabine 133Leucovorin 112pembrolizumab 99Cisplatin 93Drug Therapy 89Irinotecan 81Radiotherapy 73sintilimab 70durvalumab 65130-nm albumin-bound paclitaxel 65Paclitaxel 64Specimen Handling 62Cetuximab 61lenvatinib 59tislelizumab 58Nivolumab 55Magnetic Resonance Spectroscopy 55Folfox protocol 55Blood Specimen Collection 52atezolizumab 48Biopsy 46Surgical Procedures, Operative 40Taxes 38Albumin-Bound Paclitaxel 38Immune Checkpoint Inhibitors 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Bupivacaine × Gastrointestinal × Clear all
NCT04951804 2026-04-23

EUS-NB

Centre hospitalier de l'Université de Montréal (CHUM)

Phase NA Recruiting
180 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03715517 2026-02-05

SAFER-L

University of Manitoba

Phase NA Recruiting
128 enrolled
Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

NCT06411795 2026-02-03

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡